Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 39 tables and 46 figures, this 120-page report Asia Pacific Transcriptomics Market 2021-2031 by Component (Instruments, ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 42 tables and 37 figures, this 121-page report Europe Transcriptomics Market 2021-2031 by Component (Instruments, ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...

Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...